Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia

Fingerprint

Dive into the research topics of 'Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences